Scarica l'app Stockscreener
7.05
1.95%
-0.14
Pre-mercato:
7.27
0.22
+3.12%
Precedente Chiudi:
$7.19
Aprire:
$7.05
Volume 24 ore:
825.92K
Relative Volume:
0.55
Capitalizzazione di mercato:
$722.15M
Reddito:
$187.64M
Utile/perdita netta:
$-95.00M
Rapporto P/E:
-7.4211
EPS:
-0.95
Flusso di cassa netto:
$-69.02M
1 W Prestazione:
-4.86%
1M Prestazione:
-0.98%
6M Prestazione:
-2.35%
1 anno Prestazione:
-50.70%
Intervallo 1D:
$7.015
$7.17
Intervallo di 1 settimana:
$7.015
$7.73
Portata 52W:
$5.635
$16.76
Day One Biopharmaceuticals Inc Stock (DAWN) Company Profile
Nome
Day One Biopharmaceuticals Inc
Settore
Industria
Telefono
650 484-0899
Indirizzo
2000 SIERRA POINT PARKWAY, SUITE 501, BRISBANE
Confronta DAWN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DAWN
Day One Biopharmaceuticals Inc
|
7.05 | 736.49M | 187.64M | -95.00M | -69.02M | -0.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Day One Biopharmaceuticals Inc Stock (DAWN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-19 | Iniziato | Piper Sandler | Overweight |
| 2024-10-09 | Reiterato | Needham | Buy |
| 2024-08-01 | Aggiornamento | BofA Securities | Underperform → Buy |
| 2024-04-24 | Reiterato | Needham | Buy |
| 2023-04-25 | Downgrade | BofA Securities | Buy → Underperform |
| 2023-02-08 | Iniziato | CapitalOne | Overweight |
| 2023-02-03 | Iniziato | Oppenheimer | Perform |
| 2022-12-15 | Iniziato | H.C. Wainwright | Buy |
| 2022-12-14 | Iniziato | Needham | Buy |
| 2022-12-05 | Iniziato | Goldman | Buy |
| 2022-12-01 | Iniziato | BofA Securities | Buy |
Mostra tutto
Day One Biopharmaceuticals Inc Borsa (DAWN) Ultime notizie
Signal strength of Day One Biopharmaceuticals Inc. stock in tech scannersTrade Performance Summary & Consistent Income Trade Ideas - newser.com
Wall Street Analysts Think Day One Biopharmaceuticals (DAWN) Could Surge 241.59%: Read This Before Placing a Bet - Yahoo Finance
Can Day One Biopharmaceuticals Inc. rally from current levelsQuarterly Market Review & Consistent Profit Trading Strategies - newser.com
Detecting support and resistance levels for Day One Biopharmaceuticals Inc.Trade Volume Report & Weekly Setup with ROI Potential - newser.com
What does recent volatility data suggest for Day One Biopharmaceuticals Inc.2025 Fundamental Recap & Free Community Consensus Stock Picks - newser.com
Statistical indicators supporting Day One Biopharmaceuticals Inc.’s strength2025 Fundamental Recap & Precise Trade Entry Recommendations - newser.com
Top chart patterns to watch in Day One Biopharmaceuticals Inc.Market Volume Summary & Expert Curated Trade Setups - newser.com
Automated trading signals detected on Day One Biopharmaceuticals Inc. - newser.com
Applying Wyckoff theory to Day One Biopharmaceuticals Inc. stock2025 Price Momentum & Growth Oriented Trade Recommendations - newser.com
Is Day One Biopharmaceuticals Inc. stock oversold or undervaluedJuly 2025 Setups & AI Forecast Swing Trade Picks - newser.com
Day One Biopharmaceuticals, Inc. (DAWN) Reports Q1 Loss, Tops Revenue Estimates - sharewise.com
How to recover losses in Day One Biopharmaceuticals Inc. stockJuly 2025 EndofMonth & Free Low Drawdown Momentum Trade Ideas - newser.com
Published on: 2025-10-10 04:42:27 - newser.com
Weiss Ratings Reiterates Sell (E+) Rating for Day One Biopharmaceuticals (NASDAQ:DAWN) - MarketBeat
Published on: 2025-10-09 05:35:06 - newser.com
Day One Biopharmaceuticals Hits Day Low of $7.27 Amid Price Pressure - Markets Mojo
Day One Biopharmaceuticals (NASDAQ:DAWN) Trading Down 5.5%Time to Sell? - MarketBeat
Day One Biopharmaceuticals (DAWN) Moves 7.0% Higher: Will This Strength Last? - Nasdaq
How to read the order book for Day One Biopharmaceuticals Inc.2025 Analyst Calls & Consistent Profit Trade Alerts - newser.com
Smart tools for monitoring Day One Biopharmaceuticals Inc.’s price actionStock Surge & AI Forecasted Entry/Exit Points - newser.com
Can volume confirm reversal in Day One Biopharmaceuticals Inc.Trade Volume Summary & Growth Focused Stock Reports - newser.com
Day One Biopharmaceuticals Experiences Evaluation Revision Amidst Market Challenges and Mixed Performance Indicators - Markets Mojo
Live market analysis of Day One Biopharmaceuticals Inc.2025 Key Lessons & AI Forecasted Entry and Exit Points - newser.com
What makes Day One Biopharmaceuticals Inc. stock attractive to growth fundsWeekly Market Outlook & Low Risk High Win Rate Stock Picks - newser.com
Day One Biopharmaceuticals (NASDAQ:DAWN) Shares Up 8.4%Here's What Happened - MarketBeat
What analysts say about Day One Biopharmaceuticals Inc stockSupport Zone Identification & High Profit Market Ideas - earlytimes.in
GC Wealth Management RIA LLC Invests $520,000 in Day One Biopharmaceuticals, Inc. $DAWN - MarketBeat
Day One Biopharmaceuticals Inc Azioni (DAWN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Day One Biopharmaceuticals Inc Azioni (DAWN) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Dubow Adam | Gen Counsel & Secretary |
Aug 18 '25 |
Sale |
6.77 |
4,365 |
29,538 |
54,858 |
| Bender Jeremy | CHIEF EXECUTIVE OFFICER |
Aug 18 '25 |
Sale |
6.77 |
16,058 |
108,666 |
161,365 |
| Merendino Lauren | Chief Commercial Officer |
Aug 18 '25 |
Sale |
6.77 |
3,766 |
25,485 |
41,931 |
5.15%
1.45%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):